Skip to main content
TipRanks
Go Ultimate75% OFF

NewAmsterdam Pharma Company (NAMS) Cash flow

292 Followers

NewAmsterdam Pharma Company Cash Flow

NAMS's free cash flow for Q3 2026 was $-39.95M. For the 2026 fiscal year, NAMS's free cash flow was decreased by $-177.00K and operating cash flow was $-39.77M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Mar 23Dec 21
$ -147.78M$ -158.56M$ -141.22M$ 10.66M$ -29.51M
$ -174.92M$ -62.85M$ -24.00K$ -221.00K$ -24.00K
$ 29.52M$ 659.51M$ 8.91M$ 391.90M$ 84.70M
$ 491.32M$ 771.74M$ 340.45M$ 467.73M$ 60.13M
$ -148.03M$ -159.24M$ -141.24M$ 10.44M$ -29.54M

Currency in USD

NewAmsterdam Pharma Company Cash Flow

-400M-200M0200M400M600M800M202020212022202320242025OperatingInvestingFinancing